help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-118-5-1743
Endocrinology Vol. 118, No. 5 1743-1758
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROMANUS, J. A.
Right arrow Articles by RECHLER, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROMANUS, J. A.
Right arrow Articles by RECHLER, M. M.

Insulin-Like Growth Factor Carrier Proteins in Neonatal and Adult Rat Serum Are Immunologically Different: Demonstration Using a New Radioimmunoassay for the Carrier Protein from BRL-3A Rat Liver Cells

JOYCE A. ROMANUS, JEFFREY E. TERRELL, YVONNE W.-H. YANG*, S. PETER NISSLEY and MATTHEW M. RECHLER

Section on Growth and Development, Molecular, Cellular and Nutritional Endocrinology Branch, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases Bethesda, Maryland 20892
Endocrine Section, Metabolism Branch, National Cancer Institute, National Institutes of Health Bethesda, Maryland 20892

Address requests for reprints to: Joyce A. Romanus, National Institutes of Health, Building 10, Room 8D-14, Bethesda, Maryland 20892.

Abstract

A carrier protein for insulin-like growth factors (IGFs) has been purified from serum-free medium conditioned by the Buffalo rat liver (BRL)-3A cell line and used to immunize rabbits. Purified carrier protein was 125I labeled and affinity purified on IGF-Sepharose. The major labeled protein had a mol wt of about 33,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (appropriate for the IGF carrier protein subunit) and gave a single predominant peak of radioactivity on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and acid-urea gel electrophoresis that was immunoprecipitated by immune serum and comigrated with unlabeled proteins that bind [125I] IGF. A RIA was developed using affinity purified [125I]carrier protein and immune serum. Tracer binding was inhibited only by preparations containing IGF carrier proteins, but not by unrelated proteins or by the IGFs themselves. Carrier proteins from BRL-3A cells gave equivalent strong reactivity either after dissociation of endogenous IGF or as an IGF-carrier protein complex. The antiserum effectively recognized the approximately 40,000 mol wt (Mr ~40,000) carrier protein from neonatal rat serum, both as a native complex and after acid stripping. It did not effectively recognize the Mr ~ 150,000 carrier protein from adult rat serum either as endogenous complex or after acid stripping. These results suggest that the Mr ~40,000 carrier protein of neonatal rat serum and the Mr ~40,000 binding subunit of the Mr ~150,000 carrier protein in adult rat serum are immunologically distinct. These antisera to the BRL-3A carrier protein should be useful tools with which to dissect the relationships between different carrier protein species and to study the regulation of IGF carrier protein gene expression. (Endocrinology 118: 1743–1758, 1986)

Footnotes

* Present address: Biotechnology Research Center, Meloy/Rorer Group, Inc., 2501 Research Boulevard, Rockville, Maryland 20850.

1For simplicity, carrier proteins are designated as Mr ~150,000 or Mr ~40,000. These numbers represent approximate mol wt. This designation is not intended to imply that all Mr ~150,000 and all Mr ~40,000 species are identical.

Received June 7, 1985.




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin
IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury
Endocrinology, October 1, 2001; 142(10): 4420 - 4427.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. L. Wood, L. E. Rogler, M. E. Czick, A. G.P. Schuller, and J. E. Pintar
Selective Alterations in Organ Sizes in Mice with a Targeted Disruption of the Insulin-Like Growth Factor Binding Protein-2 Gene
Mol. Endocrinol., September 1, 2000; 14(9): 1472 - 1482.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. C. Villafuerte, W. Zhao, A. C. Herington, R. Saffery, and L. S. Phillips
Identification of an Insulin-responsive Element in the Rat Insulin-like Growth Factor-binding Protein-3 Gene
J. Biol. Chem., February 21, 1997; 272(8): 5024 - 5030.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society